Please provide your email address to receive an email when new articles are posted on . This two-part series will review innovative sustained-delivery options in the retina space for both long- and ...
Please provide your email address to receive an email when new articles are posted on . One-fifth of patients who received ocular steroid injections were later diagnosed with glaucoma or ocular ...
June 24, 2009 — On June 17, the US Food and Drug Administration (FDA) approved a dexamethasone 0.7-mg intravitreal implant (Ozurdex, Allergan, Inc) for the treatment of macular edema after branch ...
Reduced treatment burden for neovascular age-related macular degeneration met with overwhelming approval in an analysis of patient-reported outcomes (PROs) from a randomized trial. After 40 weeks of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results